Hyperfine (HYPR) Return on Capital Employed Growth (1y) (2022 - 2026)
Hyperfine (HYPR) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 125.00 |
| 10 | Hyperfine | 93.72 Mn | 52.44 Mn | 1.98 Mn | 1,736.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,736.00 |
| Dec 31, 2025 | -2,317.00 |
| Sep 30, 2025 | -5,108.00 |
| Jun 30, 2025 | -4,007.00 |
| Mar 31, 2025 | -3,385.00 |
| Dec 31, 2024 | -2,446.00 |
| Sep 30, 2024 | -1,963.00 |
| Jun 30, 2024 | -1,489.00 |
| Mar 31, 2024 | -384.00 |
| Dec 31, 2023 | 226.00 |
| Sep 30, 2023 | 1,025.00 |
| Jun 30, 2023 | 873.00 |
| Mar 31, 2023 | -748.00 |
| Dec 31, 2022 | -2,156.00 |